1-Aminocyclopropanecarboxylic Acid

Identification

Generic Name
1-Aminocyclopropanecarboxylic Acid
DrugBank Accession Number
DB02085
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 101.1039
Monoisotopic: 101.047678473
Chemical Formula
C4H7NO2
Synonyms
Not Available
External IDs
  • NSC-98430

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
U1-aminocyclopropane-1-carboxylate deaminaseNot AvailablePseudomonas sp. (strain ACP)
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as alpha amino acids. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon).
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Carboxylic acids and derivatives
Sub Class
Amino acids, peptides, and analogues
Direct Parent
Alpha amino acids
Alternative Parents
1-aminocyclopropane-1-carboxylic acids and derivatives / Cyclopropanecarboxylic acids / Amino acids / Monocarboxylic acids and derivatives / Carboxylic acids / Organopnictogen compounds / Organic oxides / Monoalkylamines / Hydrocarbon derivatives / Carbonyl compounds
Substituents
1-aminocyclopropane-1-carboxylic acid or derivatives / Aliphatic homomonocyclic compound / Alpha-amino acid / Amine / Amino acid / Carbonyl group / Carboxylic acid / Cyclopropanecarboxylic acid / Cyclopropanecarboxylic acid or derivatives / Hydrocarbon derivative
Molecular Framework
Aliphatic homomonocyclic compounds
External Descriptors
monocarboxylic acid, non-proteinogenic alpha-amino acid (CHEBI:18053)
Affected organisms
Not Available

Chemical Identifiers

UNII
3K9EJ633GL
CAS number
22059-21-8
InChI Key
PAJPWUMXBYXFCZ-UHFFFAOYSA-N
InChI
InChI=1S/C4H7NO2/c5-4(1-2-4)3(6)7/h1-2,5H2,(H,6,7)
IUPAC Name
1-aminocyclopropane-1-carboxylic acid
SMILES
NC1(CC1)C(O)=O

References

Synthesis Reference

Wolfgang Kleemiss, Marcel Feld, "Process for the preparation of 1-aminocyclopropanecarboxylic acid hydrochloride." U.S. Patent US5569781, issued October 29, 1996.

US5569781
General References
Not Available
Human Metabolome Database
HMDB0036458
KEGG Compound
C01234
PubChem Compound
535
PubChem Substance
46505058
ChemSpider
520
ChEBI
18053
ChEMBL
CHEMBL265325
ZINC
ZINC000000895536
PDBe Ligand
1AC
PDB Entries
1j0e / 1tz2 / 1y20 / 2gv2 / 2rc9 / 3fe7 / 3fea / 3ov1 / 4tll / 4tlm
show 1 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
PropertyValueSource
logP-2.78TSAI,RS ET AL. (1991)
pKa2.73TSAI,RS ET AL. (1991)
Predicted Properties
PropertyValueSource
Water Solubility437.0 mg/mLALOGPS
logP-3ALOGPS
logP-2.7Chemaxon
logS0.64ALOGPS
pKa (Strongest Acidic)2.2Chemaxon
pKa (Strongest Basic)9.35Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count3Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area63.32 Å2Chemaxon
Rotatable Bond Count1Chemaxon
Refractivity23.25 m3·mol-1Chemaxon
Polarizability9.6 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.8158
Blood Brain Barrier+0.8236
Caco-2 permeable-0.611
P-glycoprotein substrateNon-substrate0.6972
P-glycoprotein inhibitor INon-inhibitor0.9921
P-glycoprotein inhibitor IINon-inhibitor0.9927
Renal organic cation transporterNon-inhibitor0.944
CYP450 2C9 substrateNon-substrate0.823
CYP450 2D6 substrateNon-substrate0.8582
CYP450 3A4 substrateNon-substrate0.7249
CYP450 1A2 substrateNon-inhibitor0.9265
CYP450 2C9 inhibitorNon-inhibitor0.9399
CYP450 2D6 inhibitorNon-inhibitor0.9683
CYP450 2C19 inhibitorNon-inhibitor0.9418
CYP450 3A4 inhibitorNon-inhibitor0.9305
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9888
Ames testNon AMES toxic0.8466
CarcinogenicityNon-carcinogens0.8423
BiodegradationReady biodegradable0.7264
Rat acute toxicity2.2509 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9958
hERG inhibition (predictor II)Non-inhibitor0.9776
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-MS (1 TMS)GC-MSsplash10-001i-9500000000-33713ec79986844e5473
GC-MS Spectrum - GC-MS (2 TMS)GC-MSsplash10-0ufr-3950000000-776d858758510d8fe3b8
GC-MS Spectrum - GC-MS (3 TMS)GC-MSsplash10-00di-1910000000-acee5ab7198285e8e50d
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-056r-9000000000-0f66197492d04223590a
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0002-1910000000-836cd3fd9e3e118fac61
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0002-0920000000-7a5478a80a1eb32d4b7a
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-00di-9720000000-bc94d2ac28653eae38a4
GC-MS Spectrum - GC-MSGC-MSsplash10-00di-1910000000-acee5ab7198285e8e50d
GC-MS Spectrum - GC-MSGC-MSsplash10-001i-9500000000-33713ec79986844e5473
GC-MS Spectrum - GC-MSGC-MSsplash10-0ufr-3950000000-776d858758510d8fe3b8
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0002-0920000000-af1ef43c6c84ceb25d5c
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0udi-1900000000-6ca112489bfda003824d
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0002-9000000000-bd4a1c4cd402aa288a76
LC-MS/MS Spectrum - LC-ESI-QTOF , negativeLC-MS/MSsplash10-0udi-1900000000-a1d7dde23e88cd41768a
MS/MS Spectrum - , negativeLC-MS/MSsplash10-0udi-1900000000-efae844e876c90b68fef
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0udi-0900000000-77275125d96326d211b2
MS/MS Spectrum - , positiveLC-MS/MSsplash10-0pb9-9600000000-4cea9188f7383df64f1e
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-9000000000-4d39dc9db4b71fee8c13
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0udi-2900000000-effb43830340b9f51a6d
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-9000000000-443c6931979a061fab9f
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0udi-1900000000-27e3c27707454de01f40
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4l-9000000000-a0414b3c7493cad2ae68
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-059i-9000000000-bbb700dcbd4665091d1f
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-112.5468809
predicted
DarkChem Lite v0.1.0
[M-H]-112.3460809
predicted
DarkChem Lite v0.1.0
[M-H]-112.4585809
predicted
DarkChem Lite v0.1.0
[M-H]-119.312225
predicted
DeepCCS 1.0 (2019)
[M+H]+111.5934809
predicted
DarkChem Lite v0.1.0
[M+H]+111.7582809
predicted
DarkChem Lite v0.1.0
[M+H]+111.6717809
predicted
DarkChem Lite v0.1.0
[M+H]+122.111084
predicted
DeepCCS 1.0 (2019)
[M+Na]+112.6839809
predicted
DarkChem Lite v0.1.0
[M+Na]+112.9304809
predicted
DarkChem Lite v0.1.0
[M+Na]+130.2639
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Pseudomonas sp. (strain ACP)
Pharmacological action
Unknown
General Function
Pyridoxal phosphate binding
Specific Function
Catalyzes a cyclopropane ring-opening reaction, the irreversible conversion of 1-aminocyclopropane-1-carboxylate (ACC) to ammonia and alpha-ketobutyrate. Allows growth on ACC as a nitrogen source.
Gene Name
acdS
Uniprot ID
Q00740
Uniprot Name
1-aminocyclopropane-1-carboxylate deaminase
Molecular Weight
36671.515 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52